Garfield Township, Michigan – December 05, 2025 – PRESSADVANTAGE – A growing number of investors are reconsidering how they ...
AJN Resources Inc. ( ($TSE:AJN) ) has shared an update. AJN Resources Inc. has announced a repricing of its private placement unit offering to ...
Private placement debt offerings offer a compelling alternative to traditional lending for many companies. The legal landscape governing these transactions involves key statutes, regulations, and the ...
Rule 144A and Regulation D offer exemptions from federal securities registration requirements under the Securities Act of 1933. However, they apply to different situations, and overseas companies must ...
St. Augustine Gold ( ($TSE:SAU) ) has shared an update. St. Augustine Gold and Copper Limited has successfully closed a private placement of ...
Inter Media and Communication S.p.A., a subsidiary of F.C. Internazionale Milano S.p.A., and the Inter’s ownership, funds managed by Oaktree Capital Management, L.P. “Oaktree”, have agreed on ...
TORONTO, ON AND BREDA, THE NETHERLANDS / ACCESS Newswire / June 18, 2025 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) (“Organto” or the “Company“) today announced it plans to complete a ...
Aalberts announces the successful signing and closing of Note Purchase Agreements for its inaugural debt issuance in the US Private Placement (USPP) market, securing a total equivalent amount of ...
BOISE, Idaho, June 11, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or the "Company") announced today that it has entered into an agreement with ...
The completion of the private placement successfully attracted participation from approximately 40 institutional investors, indicating strong market interest in Alvotech's offerings. Over 80% of the ...
Cyclacel Pharmaceuticals announces a $3 million private placement of convertible Series F Preferred Stock and related warrants for working capital. Cyclacel Pharmaceuticals, Inc. announced a private ...
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback